Value of Urine Peptides in Assessing Kidney and Cardiovascular Disease
- 25 July 2020
- journal article
- review article
- Published by Wiley in Proteomics – Clinical Applications
- Vol. 15 (1), e2000027
- https://doi.org/10.1002/prca.202000027
Abstract
Urinary peptides gained significant attention as potential biomarkers especially in the context of kidney and cardiovascular disease. In this manuscript the recent literature since 2015 on urinary peptide investigation in human kidney and cardiovascular disease is reviewed. The technology most commonly used in this context is capillary electrophoresis coupled mass spectrometry, in part owed to the large database available and the well‐defined dataspace. Several studies based on over 1000 subjects were reported in the recent past, especially examining CKD273, a classifier for assessment of chronic kidney disease based on 273 urine peptides. Interestingly, the most abundant urinary peptides are generally collagen fragments, which may have gone undetected for some time as they are typically modified via proline hydroxylation. The data available suggest that urinary peptides specifically depict inflammation and fibrosis, and may serve as a non‐invasive tool to assess fibrosis, which appears to be a key driver in kidney and cardiovascular disease. The recent successful completion of the first urinary peptide guided intervention trial, PRIORITY, is expected to further spur clinical application of urinary peptidomics, aiming especially at early detection of chronic diseases, prediction of progression and prognosis of drug response. This article is protected by copyright. All rights reservedKeywords
Funding Information
- Fondation pour la Recherche Médicale (DEQ20170336759)
- Agence Nationale de la Recherche (ANR‐17‐ECVD‐0006, ANR‐18‐PERM‐0003)
- Bundesministerium für Bildung und Forschung (01KU1907, 01KU1922A, 01KU1922B)
This publication has 86 references indexed in Scilit:
- A comparison between MALDI-MS and CE-MS data for biomarker assessment in chronic kidney diseasesJournal of Proteomics, 2012
- Urinary proteome analysis in hypertensive patients with left ventricular diastolic dysfunctionEuropean Heart Journal, 2012
- Urinary excretion of twenty peptides forms an early and accurate diagnostic pattern of acute kidney injuryKidney International, 2010
- Naturally Occurring Human Urinary Peptides for Use in Diagnosis of Chronic Kidney DiseaseMolecular & Cellular Proteomics, 2010
- Urinary proteomic diagnosis of coronary artery disease: identification and clinical validation in 623 individualsJournal of Hypertension, 2010
- CE‐MS in biomarker discovery, validation, and clinical applicationProteomics – Clinical Applications, 2010
- The human urinary proteome reveals high similarity between kidney aging and chronic kidney diseaseProteomics, 2009
- Quantitative Urinary Proteome Analysis for Biomarker Evaluation in Chronic Kidney DiseaseJournal of Proteome Research, 2008
- Urine in Clinical ProteomicsMolecular & Cellular Proteomics, 2008
- Matrix metalloproteinases and the regulation of tissue remodellingNature Reviews Molecular Cell Biology, 2007